The UK is hosting the 2020 replenishment conference for Gavi – the Vaccine Alliance – in the hopes of raising £7.4 billion for immunisation programmes in the developing world over the next five years.
Following the announcement to ease lockdown measures in England, the UK government has published guidance to support the safe return to work for people in various sectors.
The NIHR has set out a framework for the resumption of health research that was paused as a result of the COVID-19 pandemic.
The Chief Executive of the ABPI has today told the International Trade Committee that the coronavirus pandemic shows why resilient, global supply of medicines is so important.
The UK Government has put out a ‘call to arms’ to the life sciences industry to help them rapidly develop coronavirus testing as part of the Health Secretary’s pledge to carry out 100,000 tests a day by the end of April.
Four trade bodies representing the life sciences sector have released a joint statement on testing kits for COVID-19.
The Department of Health and Social Care has published the latest Voluntary Scheme sales data for Q4 2019 which brings the total branded growth rate for 2019 versus 2018 to 1.6%.
As a critical part of the health care community in the UK, the pharmaceutical industry wants to play the biggest possible role in the response to this outbreak.
The Chancellor Rishi Sunak has delivered his first Budget, and the first for the Government following last year's General Election.
The Department for International Trade has published the UK's approach to free trade negotiations with the US.